ℹ️
🇬🇧
Search
Search for people relevant for "Bevacizumab"
Bevacizumab
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Petr Zatloukal CSc.
External person at Third Faculty of Medicine
2 classes
83 publications
Classes
class
Selected Topics on Diagnostics of Lung Cancer
CCOC7837 |
Third Faculty of Medicine
class
Diagnosis and treatment of lung cancer
CCOC8879 |
Third Faculty of Medicine
Publications
publication
Follow-up of expensive pneumo-oncological treatment of advanced non-small cell lung cancer in the I. line of the TULUNG register in the Czech Republic
2013 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
publication
Clinical registry TULUNG
2012 |
Faculty of Medicine in Pilsen, Third Faculty of Medicine
publication
Monitoring of the expensive pneumooncological tratment of the advanced non-small cell lung cancer (NSCLC) in the 1st line in the TULUNG registry in the Czech Republic
2012 |
Third Faculty of Medicine, First Faculty of Medicine
publication
Endogenous and exogenous oestrogen exposure in Women and Lung cancer
2014 |
Third Faculty of Medicine
publication
New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic
2012 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
publication
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer
2012 |
Third Faculty of Medicine
publication
A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
2012 |
Third Faculty of Medicine
publication
Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non-Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy
2012 |
Third Faculty of Medicine
publication
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
2012 |
Third Faculty of Medicine
publication
Interdisciplinary consensus for predictive testing of activation mutations of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer
2011 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
Load more publications (73)
Loading network view...